4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one

C28H41N3O2 — CID 110195917

IUPAC4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one
SMILESCC1CCN(C(=O)CCC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN2C(=O)c2ccccc2)[C@@H]34)CC1
InChIInChI=1S/C28H41N3O2/c1-21-14-18-29(19-15-21)26(32)13-5-12-25-24-11-7-17-30-16-6-10-23(27(24)30)20-31(25)28(33)22-8-3-2-4-9-22/h2-4,8-9,21,23-25,27H,5-7,10-20H2,1H3/t23-,24+,25+,27-/m0/s1
InChIKeyQAPLEWOADWEJDN-FCRYVSRXSA-N
MW451.66 g/mol
LogP4.43
Rot. Bonds5

About 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one

4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one (PubChem CID 110195917) has the molecular formula C28H41N3O2 and a molecular weight of 451.66 g/mol. Its IUPAC name is 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one.

Molecular Properties

Compound Name4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one
PubChem CID110195917
Molecular FormulaC28H41N3O2
Molecular Weight451.66 g/mol
Exact Mass451.32
IUPAC Name4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one
SMILESCC1CCN(C(=O)CCC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN2C(=O)c2ccccc2)[C@@H]34)CC1
InChIInChI=1S/C28H41N3O2/c1-21-14-18-29(19-15-21)26(32)13-5-12-25-24-11-7-17-30-16-6-10-23(27(24)30)20-31(25)28(33)22-8-3-2-4-9-22/h2-4,8-9,21,23-25,27H,5-7,10-20H2,1H3/t23-,24+,25+,27-/m0/s1
InChIKeyQAPLEWOADWEJDN-FCRYVSRXSA-N
XLogP4.43
TPSA43.86 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500451.66
LogP ≤ 54.43
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Analyze 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one?
The IUPAC name of 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one (CID 110195917) is 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one.
What is the SMILES notation for 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one?
The canonical SMILES for 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one is CC1CCN(C(=O)CCC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN2C(=O)c2ccccc2)[C@@H]34)CC1.
What is the InChIKey of 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one?
The InChIKey is QAPLEWOADWEJDN-FCRYVSRXSA-N. The full InChI is InChI=1S/C28H41N3O2/c1-21-14-18-29(19-15-21)26(32)13-5-12-25-24-11-7-17-30-16-6-10-23(27(24)30)20-31(25)28(33)22-8-3-2-4-9-22/h2-4,8-9,21,23-25,27H,5-7,10-20H2,1H3/t23-,24+,25+,27-/m0/s1.
What are the key properties of 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one?
4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one has a molecular weight of 451.66 g/mol, XLogP of 4.43, 5 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(5R,6R,9S,13S)-7-benzoyl-1,7-diazatricyclo[7.3.1.05,13]tridecan-6-yl]-1-(4-methylpiperidin-1-yl)butan-1-one is sourced from PubChem (CID 110195917), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).